It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium includes access to the Zacks Style ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these Wall Street heavyweights have to say about Tenet Healthcare (THC) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. Tenet currently has an average brokerage recommendatio ...

Hospital and ambulatory care operator Tenet Healthcare Co. NYSE: THC is operating in the sweet spot of healthcare these days. That sweet spot is acute care services, which include emergency departments, inpatient hospitalizations, and ambulatory care. The company had the foresight to focus its concentration on acute care and is riding the unforeseen acute care boom. Tenet Healthcare Today | --- | --- | |----------------------|-------| | | | | | | | THC | | | Tenet Healthcare | | | $146.18 | | | +1.19 (+0.82 ...

Tenet Healthcare (THC) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this hospital operator have returned +10.2%, compared to the Zacks S&P 500 composite's +1.1% change. During this period, the Zacks Medical - Hospital industry, which Tenet falls in, has gained 12.1%. The key question now is: What could be the stock's future direction? Although ...

Financial Performance - Consolidated net operating revenues increased by $21 million, or 0.4%, in the three months ended June 30, 2024 compared to the same period in 2023[252]. - Total revenues for the company were $5.103 billion in the three months ended June 30, 2024, a slight increase of 0.4% from $5.082 billion in the same period of 2023[280]. - Net income available to common shareholders for diluted earnings per share was $2.64 for the three months ended June 30, 2024, compared to $1.15 for the same period in 2023[301]. - Income before income taxes for the three months ended June 30, 2024, was $587 million, up from $373 million in the same period of 2023, indicating a 57% increase[387]. - Adjusted EBITDA for the six months ended June 30, 2024, was $1.969 billion, compared to $1.675 billion for the same period in 2023, reflecting a 17.6% increase[391]. Admissions and Patient Services - Total admissions decreased by 8,128, or 6.1%, in the three months ended June 30, 2024 compared to the same period in 2023[251]. - Total admissions decreased by 6.1% to 124,626 in the three months ended June 30, 2024, compared to 132,754 in the same period of 2023[278]. - The average length of stay decreased to 5.00 days in the three months ended June 30, 2024, from 5.10 days in the same period of 2023[278]. - The company experienced a 20.0% increase in total consolidated cases in the Ambulatory Care segment, driven by acquired ASCs and same-facility case growth[279]. Revenue Segments - The decrease of $178 million, or 4.3%, in the Hospital Operations segment's net operating revenues for the three-month period in 2024 was primarily due to the sales of divested hospitals[252]. - Net operating revenues in the Ambulatory Care segment increased by $199 million, or 21.1%, in the three months ended June 30, 2024, compared to the same period in 2023[282]. - Total net operating revenues for Hospital Operations were $3,962 million for the three months ended June 30, 2024, compared to $4,140 million for the same period in 2023[303]. - Total net patient service revenues from continuing operations for the Hospital Operations segment were $518 million for the three months ended June 30, 2024, compared to $599 million for the same period in 2023, reflecting a decrease of 13.5%[324]. Operating Expenses - Salaries, wages, and benefits per adjusted admission increased by 0.5% to $8,263 in the three months ended June 30, 2024[254]. - Supplies per adjusted admission increased by 4.0% to $2,670 in the same period[254]. - Other operating expenses per adjusted admission increased by 7.3% to $4,290 in the three months ended June 30, 2024[256]. - Operating expenses for Hospital Operations decreased by 5.5% to $3.472 billion in the three months ended June 30, 2024, compared to $3.676 billion in the same period of 2023[283]. - Same-hospital salaries, wages, and benefits expense increased by $36 million, or 2.0%, in the three months ended June 30, 2024, while as a percentage of net operating revenues, it decreased by 270 basis points to 47.0%[364]. - Same-hospital supplies expense increased by $36 million, or 6.3%, in the three months ended June 30, 2024, driven by higher patient volumes[366]. - Other operating expenses increased by $76 million, or 8.5%, in the three months ended June 30, 2024, with malpractice and medical fees contributing significantly to the rise[367]. Cash Flow and Investments - Net cash provided by operating activities was $1.333 billion in the six months ended June 30, 2024, compared to $1.047 billion in the same period in 2023[257]. - Cash and cash equivalents increased to $2.880 billion at June 30, 2024, up from $2.481 billion at March 31, 2024[286]. - The company recorded net cash provided by investing activities of $3.134 billion during the six months ended June 30, 2024, compared to net cash used of $467 million in the same period of 2023[398]. - The company had $2.880 billion of cash and cash equivalents on hand at June 30, 2024, to fund operations and capital expenditures[396]. Acquisitions and Growth - The company acquired controlling ownership interests in 49 ambulatory surgery centers (ASCs) during the six months ended June 30, 2024[243]. - The company opened six de novo ASCs with noncontrolling ownership interests during the same period[243]. - The company made facility acquisitions totaling $500 million during the six months ended June 30, 2024, compared to $96 million in the same period of 2023[380]. - The company plans to invest $250 million annually in ambulatory business acquisitions and de novo facilities as part of its portfolio diversification strategy[394]. Shareholder Returns - The board of directors authorized a share repurchase program of up to $1.5 billion with no expiration date in July 2024[238]. - The company repurchased $548 million worth of common stock, acquiring 4,801 thousand shares at an average price of $114.19 per share in the six months ended June 30, 2024[276]. Restructuring and Legal Matters - The company incurred restructuring charges in the six months ended June 30, 2024, with potential for additional charges in the future[272]. - Restructuring charges for the six months ended June 30, 2024 totaled $32 million, compared to $31 million for the same period in 2023, with legal costs related to business sales being a significant component[356]. - Litigation and investigation costs amounted to $9 million for the six months ended June 30, 2024, down from $14 million in the same period of 2023[357]. Tax and Regulatory Matters - The company expects a $4 million decrease in unrecognized federal and state tax benefits in the next 12 months due to audit settlements and amended tax returns[333]. - The company amended its letter of credit facility to extend the maturity date to March 16, 2027, and replaced LIBOR with Term SOFR as the reference interest rate[326].

While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Tenet Healthcare curr ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. It also includes access to the Zacks Style Scores. Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days. The Style Scores are broken down into four categ ...

Earnings were strong last quarter. HCA Healthcare, Inc. beat our consensus estimate by 10.66%, and for the current fiscal year, HCA is expected to post earnings of $21.37 per share on revenue of $69.35 billion. Have you been paying attention to shares of Tenet Healthcare (THC) ? Shares have been on the move with the stock up 7.1% over the past month. The stock hit a new 52-week high of $151 in the previous session. Tenet Healthcare has gained 92.3% since the start of the year compared to the 7.3% move for t ...

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, inves ...

Tenet Healthcare's stock rose to highs not seen in more than two decades as earnings growth and an improved revenue outlook lifted the stock. Tenet is the second hospital provider to post strong numbers this week, joining HCA Healthcare. Shares of Tenet are up more than 90% in 2024. Tenet Healthcare (THC) shares soared to a more than two-decade high after the hospital and surgical center chain posted stronger-than-expected results and boosted its outlook as it brought in more patients who paid more for serv ...